Neurological Diseases

Strategic objectives

To advance knowledge of neurological diseases, with special attention to:

  • Neurogenesis and neurorepair
  • Multiple sclerosis and neuroimmunity
  • Amyotrophic lateral sclerosis
  • Clinical and neuroimaging biomarkers in neurodegenerative diseases
  • Role of lipids in neurodegeneration
  • Epidemiology of rare headaches
  • Development of epilepsy prognostic factors
  • Technical development in movement disorders
  • Assessment of factors associated with narcolepsy
  • Neurogenetics in neurological diseases
  • Therapeutic advances

Lines of research

  • Cognitive neurology, neuroimaging, and neuromodulation research.
  • Research in multiple sclerosis, neuroimmunology, and neuroimmune diseases.
  • Research in movement disorders
  • Epilepsy research
  • Stroke and cerebrovascular diseases research
  • Research in migraine, other headaches, and pain
  • Research in amyotrophic lateral sclerosis and neuromuscular diseases
  • Research in neuroamyloidosis in the peripheral nervous system
  • Research in molecular basis of neurogeneration and neuroregeneration in neurological diseases
  • Research in lipid basis of neurodegeneration in neurological diseases
  • Sleeping disorders research
  • Research in neurophysiology applied to neurological diseases ​

Other members of the group

Publications

Projects